Filter

Refine by date

—

Refine by collections

Refine by access

  • Print
  • Save

Search Results

You are looking at 31 - 40 of 677 items for :

  • "metabolic syndrome" x
  • Refine by access: All content x
Clear All
Christine A Beamish Department of Surgery, Houston Methodist Research Institute, Houston, Texas, USA

Search for other papers by Christine A Beamish in
Google Scholar
PubMed Close
,
Yoon K Lee Department of Surgery, Houston Methodist Research Institute, Houston, Texas, USA

Search for other papers by Yoon K Lee in
Google Scholar
PubMed Close
,
A Osama Gaber Department of Surgery, Houston Methodist Research Institute, Houston, Texas, USA

Search for other papers by A Osama Gaber in
Google Scholar
PubMed Close
,
Priyanka Chanana Department of Surgery, Houston Methodist Research Institute, Houston, Texas, USA

Search for other papers by Priyanka Chanana in
Google Scholar
PubMed Close
,
Edward A Graviss Department of Surgery, Houston Methodist Research Institute, Houston, Texas, USA
Department of Pathology and Genomic Medicine, Houston Methodist Research Institute, Houston, Texas, USA

Search for other papers by Edward A Graviss in
Google Scholar
PubMed Close
,
Malgorzata Kloc Department of Surgery, Houston Methodist Research Institute, Houston, Texas, USA
Department of Cell and Microbiology, Weill Cornell Medical College, New York, New York, USA
Department of Genetics, The University of Texas Anderson Cancer Center, Houston, Texas, USA

Search for other papers by Malgorzata Kloc in
Google Scholar
PubMed Close
,
M Waleed Gaber Department of Pediatrics, Hematology-Oncology Section, Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, Texas, USA
Department of Molecular Physiology & Biophysics, Baylor College of Medicine, Houston, Texas, USA

Search for other papers by M Waleed Gaber in
Google Scholar
PubMed Close
,
Willa A Hsueh Department of Internal Medicine, The Ohio State University Diabetes and Metabolism Research Center, Columbus, Ohio, USA

Search for other papers by Willa A Hsueh in
Google Scholar
PubMed Close
, and
Omaima M Sabek Department of Surgery, Houston Methodist Research Institute, Houston, Texas, USA
Department of Cell and Microbiology, Weill Cornell Medical College, New York, New York, USA

Search for other papers by Omaima M Sabek in
Google Scholar
PubMed Close

Introduction The confluence of factors that characterize metabolic syndrome (MetS) are prevalent in the Western world and includes hypertension, abdominal obesity, elevated fasting glucose, insulin resistance (IR), elevated blood triglycerides

Article Type:
Research Article
DOI:
https://doi.org/10.1530/JOE-23-0352
Volume/Issue:
Volume 261: Issue 1
Restricted access
G Boaventura
Search for other papers by G Boaventura in
Google Scholar
PubMed Close
,
G Casimiro-Lopes
Search for other papers by G Casimiro-Lopes in
Google Scholar
PubMed Close
,
C C Pazos-Moura Departamento de Ciências Fisiológicas, Instituto de Biofisica Carlos Chagas Filho, 5° Andar, Instituto de Biologia Roberto Alcantara Gomes, Universidade do Estado do Rio de Janeiro, Avenida 28 de Setembro, 87, Rio de Janeiro 20551-030, Brazil

Search for other papers by C C Pazos-Moura in
Google Scholar
PubMed Close
,
E Oliveira
Search for other papers by E Oliveira in
Google Scholar
PubMed Close
,
P C Lisboa
Search for other papers by P C Lisboa in
Google Scholar
PubMed Close
, and
E G Moura
Search for other papers by E G Moura in
Google Scholar
PubMed Close

resistance and an altered lipid profile) are similar to those of metabolic syndrome ( Moura et al . 2009 ). More recently, we obtained a similar profile in adult animals with a non-pharmacological model where a maternal bandage was used to cover the teats of

Article Type:
Research Article
DOI:
https://doi.org/10.1530/JOE-13-0102
Volume/Issue:
Volume 219: Issue 1
Free access
Shelley Gorman Telethon Kids Institute, University of Western Australia, Perth, Australia

Search for other papers by Shelley Gorman in
Google Scholar
PubMed Close
,
Alexander N Larcombe Telethon Kids Institute, Perth, Australia
School of Population Health, Curtin University, Perth, Australia

Search for other papers by Alexander N Larcombe in
Google Scholar
PubMed Close
, and
Hayley E Christian Telethon Kids Institute, University of Western Australia, Perth, Australia

Search for other papers by Hayley E Christian in
Google Scholar
PubMed Close

dysfunction. One increasingly important example of metabolic dysfunction is metabolic syndrome, a cluster of conditions (high blood pressure, high blood glucose, abdominal adiposity and hyperlipidaemia) that increase the risk of heart disease, stroke and

Article Type:
Review Article
DOI:
https://doi.org/10.1530/JOE-20-0487
Volume/Issue:
Volume 249: Issue 1
Free access
K Alexander H Iwen Department of Internal Medicine I, University of Lübeck, Ratzeburger Allee 160, 23538 Lübeck, Germany

Search for other papers by K Alexander H Iwen in
Google Scholar
PubMed Close
,
Oezge Senyaman Department of Internal Medicine I, University of Lübeck, Ratzeburger Allee 160, 23538 Lübeck, Germany

Search for other papers by Oezge Senyaman in
Google Scholar
PubMed Close
,
Arne Schwartz Department of Internal Medicine I, University of Lübeck, Ratzeburger Allee 160, 23538 Lübeck, Germany

Search for other papers by Arne Schwartz in
Google Scholar
PubMed Close
,
Maren Drenckhan Department of Internal Medicine I, University of Lübeck, Ratzeburger Allee 160, 23538 Lübeck, Germany

Search for other papers by Maren Drenckhan in
Google Scholar
PubMed Close
,
Britta Meier Department of Internal Medicine I, University of Lübeck, Ratzeburger Allee 160, 23538 Lübeck, Germany

Search for other papers by Britta Meier in
Google Scholar
PubMed Close
,
Dirk Hadaschik Department of Internal Medicine I, University of Lübeck, Ratzeburger Allee 160, 23538 Lübeck, Germany

Search for other papers by Dirk Hadaschik in
Google Scholar
PubMed Close
, and
Johannes Klein Department of Internal Medicine I, University of Lübeck, Ratzeburger Allee 160, 23538 Lübeck, Germany

Search for other papers by Johannes Klein in
Google Scholar
PubMed Close

Introduction Obesity and insulin resistance are at the centre of the metabolic syndrome which is a major risk factor for the development of cardiovascular disease. There is growing evidence for an implication of adipose dysfunction critically

Article Type:
Research Article
DOI:
https://doi.org/10.1677/JOE-07-0299
Volume/Issue:
Volume 196: Issue 3
Free access
Qinkai Li Key Laboratory for Atherosclerology of Hunan Province, Department of Nutrition and Metabolism, Clinical Research Center for Diabetes, Institute of Cardiovascular Research, Life Science Research Center, University of South China, Hengyang, Hunan 421001, People's Republic of China
Key Laboratory for Atherosclerology of Hunan Province, Department of Nutrition and Metabolism, Clinical Research Center for Diabetes, Institute of Cardiovascular Research, Life Science Research Center, University of South China, Hengyang, Hunan 421001, People's Republic of China
Key Laboratory for Atherosclerology of Hunan Province, Department of Nutrition and Metabolism, Clinical Research Center for Diabetes, Institute of Cardiovascular Research, Life Science Research Center, University of South China, Hengyang, Hunan 421001, People's Republic of China

Search for other papers by Qinkai Li in
Google Scholar
PubMed Close
,
Weidong Yin Key Laboratory for Atherosclerology of Hunan Province, Department of Nutrition and Metabolism, Clinical Research Center for Diabetes, Institute of Cardiovascular Research, Life Science Research Center, University of South China, Hengyang, Hunan 421001, People's Republic of China

Search for other papers by Weidong Yin in
Google Scholar
PubMed Close
,
Manbo Cai Key Laboratory for Atherosclerology of Hunan Province, Department of Nutrition and Metabolism, Clinical Research Center for Diabetes, Institute of Cardiovascular Research, Life Science Research Center, University of South China, Hengyang, Hunan 421001, People's Republic of China

Search for other papers by Manbo Cai in
Google Scholar
PubMed Close
,
Yi Liu Key Laboratory for Atherosclerology of Hunan Province, Department of Nutrition and Metabolism, Clinical Research Center for Diabetes, Institute of Cardiovascular Research, Life Science Research Center, University of South China, Hengyang, Hunan 421001, People's Republic of China

Search for other papers by Yi Liu in
Google Scholar
PubMed Close
,
Hongjie Hou Key Laboratory for Atherosclerology of Hunan Province, Department of Nutrition and Metabolism, Clinical Research Center for Diabetes, Institute of Cardiovascular Research, Life Science Research Center, University of South China, Hengyang, Hunan 421001, People's Republic of China

Search for other papers by Hongjie Hou in
Google Scholar
PubMed Close
,
Qingyun Shen Key Laboratory for Atherosclerology of Hunan Province, Department of Nutrition and Metabolism, Clinical Research Center for Diabetes, Institute of Cardiovascular Research, Life Science Research Center, University of South China, Hengyang, Hunan 421001, People's Republic of China

Search for other papers by Qingyun Shen in
Google Scholar
PubMed Close
,
Chi Zhang Key Laboratory for Atherosclerology of Hunan Province, Department of Nutrition and Metabolism, Clinical Research Center for Diabetes, Institute of Cardiovascular Research, Life Science Research Center, University of South China, Hengyang, Hunan 421001, People's Republic of China

Search for other papers by Chi Zhang in
Google Scholar
PubMed Close
,
Junxia Xiao Key Laboratory for Atherosclerology of Hunan Province, Department of Nutrition and Metabolism, Clinical Research Center for Diabetes, Institute of Cardiovascular Research, Life Science Research Center, University of South China, Hengyang, Hunan 421001, People's Republic of China

Search for other papers by Junxia Xiao in
Google Scholar
PubMed Close
,
Xiaobo Hu Key Laboratory for Atherosclerology of Hunan Province, Department of Nutrition and Metabolism, Clinical Research Center for Diabetes, Institute of Cardiovascular Research, Life Science Research Center, University of South China, Hengyang, Hunan 421001, People's Republic of China

Search for other papers by Xiaobo Hu in
Google Scholar
PubMed Close
,
Qishisan Wu Key Laboratory for Atherosclerology of Hunan Province, Department of Nutrition and Metabolism, Clinical Research Center for Diabetes, Institute of Cardiovascular Research, Life Science Research Center, University of South China, Hengyang, Hunan 421001, People's Republic of China

Search for other papers by Qishisan Wu in
Google Scholar
PubMed Close
,
Makoto Funaki Key Laboratory for Atherosclerology of Hunan Province, Department of Nutrition and Metabolism, Clinical Research Center for Diabetes, Institute of Cardiovascular Research, Life Science Research Center, University of South China, Hengyang, Hunan 421001, People's Republic of China

Search for other papers by Makoto Funaki in
Google Scholar
PubMed Close
, and
Yutaka Nakaya Key Laboratory for Atherosclerology of Hunan Province, Department of Nutrition and Metabolism, Clinical Research Center for Diabetes, Institute of Cardiovascular Research, Life Science Research Center, University of South China, Hengyang, Hunan 421001, People's Republic of China

Search for other papers by Yutaka Nakaya in
Google Scholar
PubMed Close

Introduction The metabolic syndrome (syndrome X) refers to the aggregation of a cluster of risk factors, including insulin resistance/hyperinsulinemia and dyslipidemia (increased low-density lipoprotein cholesterol (LDL-C), and depressed high

Article Type:
Research Article
DOI:
https://doi.org/10.1677/JOE-09-0278
Volume/Issue:
Volume 204: Issue 1
Free access
Victor P Bilan Division of Pulmonary, Medicine, Pathology, Pathology, CVGI Discovery, Diabetes Drug Discovery, Allergy, and Critical Care Medicine, Vascular Medicine Institute, Departments of
Division of Pulmonary, Medicine, Pathology, Pathology, CVGI Discovery, Diabetes Drug Discovery, Allergy, and Critical Care Medicine, Vascular Medicine Institute, Departments of

Search for other papers by Victor P Bilan in
Google Scholar
PubMed Close
,
Eman M Salah Division of Pulmonary, Medicine, Pathology, Pathology, CVGI Discovery, Diabetes Drug Discovery, Allergy, and Critical Care Medicine, Vascular Medicine Institute, Departments of
Division of Pulmonary, Medicine, Pathology, Pathology, CVGI Discovery, Diabetes Drug Discovery, Allergy, and Critical Care Medicine, Vascular Medicine Institute, Departments of

Search for other papers by Eman M Salah in
Google Scholar
PubMed Close
,
Sheldon Bastacky Division of Pulmonary, Medicine, Pathology, Pathology, CVGI Discovery, Diabetes Drug Discovery, Allergy, and Critical Care Medicine, Vascular Medicine Institute, Departments of

Search for other papers by Sheldon Bastacky in
Google Scholar
PubMed Close
,
Huw B Jones Division of Pulmonary, Medicine, Pathology, Pathology, CVGI Discovery, Diabetes Drug Discovery, Allergy, and Critical Care Medicine, Vascular Medicine Institute, Departments of

Search for other papers by Huw B Jones in
Google Scholar
PubMed Close
,
Rachel M Mayers Division of Pulmonary, Medicine, Pathology, Pathology, CVGI Discovery, Diabetes Drug Discovery, Allergy, and Critical Care Medicine, Vascular Medicine Institute, Departments of

Search for other papers by Rachel M Mayers in
Google Scholar
PubMed Close
,
Bradley Zinker Division of Pulmonary, Medicine, Pathology, Pathology, CVGI Discovery, Diabetes Drug Discovery, Allergy, and Critical Care Medicine, Vascular Medicine Institute, Departments of

Search for other papers by Bradley Zinker in
Google Scholar
PubMed Close
,
Simon M Poucher Division of Pulmonary, Medicine, Pathology, Pathology, CVGI Discovery, Diabetes Drug Discovery, Allergy, and Critical Care Medicine, Vascular Medicine Institute, Departments of

Search for other papers by Simon M Poucher in
Google Scholar
PubMed Close
, and
Stevan P Tofovic Division of Pulmonary, Medicine, Pathology, Pathology, CVGI Discovery, Diabetes Drug Discovery, Allergy, and Critical Care Medicine, Vascular Medicine Institute, Departments of
Division of Pulmonary, Medicine, Pathology, Pathology, CVGI Discovery, Diabetes Drug Discovery, Allergy, and Critical Care Medicine, Vascular Medicine Institute, Departments of

Search for other papers by Stevan P Tofovic in
Google Scholar
PubMed Close

pathways of DN to be identified, it does not share primary features of metabolic syndrome: insulin resistance/hyperinsulinemia, obesity, and hypertension. Furthermore, STZ rats develop mild hyperlipidemia and are resistant to development of nephropathy

Article Type:
Research Article
DOI:
https://doi.org/10.1530/JOE-11-0122
Volume/Issue:
Volume 210: Issue 3
Free access
Lyle Wiemerslage Department of Neuroscience, Functional Pharmacology, Uppsala University, Uppsala, Sweden

Search for other papers by Lyle Wiemerslage in
Google Scholar
PubMed Close
,
Priya A Gohel Department of Neuroscience, Functional Pharmacology, Uppsala University, Uppsala, Sweden

Search for other papers by Priya A Gohel in
Google Scholar
PubMed Close
,
Giulia Maestri Department of Neuroscience, Functional Pharmacology, Uppsala University, Uppsala, Sweden

Search for other papers by Giulia Maestri in
Google Scholar
PubMed Close
,
Torfi G Hilmarsson Department of Neuroscience, Functional Pharmacology, Uppsala University, Uppsala, Sweden

Search for other papers by Torfi G Hilmarsson in
Google Scholar
PubMed Close
,
Michel Mickael Department of Neuroscience, Functional Pharmacology, Uppsala University, Uppsala, Sweden

Search for other papers by Michel Mickael in
Google Scholar
PubMed Close
,
Robert Fredriksson Department of Neuroscience, Functional Pharmacology, Uppsala University, Uppsala, Sweden

Search for other papers by Robert Fredriksson in
Google Scholar
PubMed Close
,
Michael J Williams Department of Neuroscience, Functional Pharmacology, Uppsala University, Uppsala, Sweden

Search for other papers by Michael J Williams in
Google Scholar
PubMed Close
, and
Helgi B Schiöth Department of Neuroscience, Functional Pharmacology, Uppsala University, Uppsala, Sweden

Search for other papers by Helgi B Schiöth in
Google Scholar
PubMed Close

with the Tukey’s honestly significant difference correction. Data are reported as mean±1 s.e.m. Results TMEM18 appears to regulate metabolic syndrome via effects on insulin To find clues for TMEM18 ’s relationship with obesity, we

Article Type:
Research Article
DOI:
https://doi.org/10.1530/JOE-16-0040
Volume/Issue:
Volume 229: Issue 3
Free access
Hong-Yo Kang Graduate Institute of Clinical Medical Sciences, Hormone Research Center, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, Taiwan

Search for other papers by Hong-Yo Kang in
Google Scholar
PubMed Close

current knowledge of the metabolic and vascular actions of testosterone in these disorders – specifically, how testosterone deficiency contributes to insulin resistance, metabolic syndrome, type 2 diabetes ( Kelly & Jones 2013 a ), and cardiovascular

Article Type:
Article Commentary
DOI:
https://doi.org/10.1530/JOE-13-0052
Volume/Issue:
Volume 217: Issue 3
Free access
Harman S Mattu Division of Metabolic and Vascular Health, University of Warwick Medical School, Gibbet Hill Road, Coventry CV4 7AL, UK

Search for other papers by Harman S Mattu in
Google Scholar
PubMed Close
and
Harpal S Randeva Division of Metabolic and Vascular Health, University of Warwick Medical School, Gibbet Hill Road, Coventry CV4 7AL, UK

Search for other papers by Harpal S Randeva in
Google Scholar
PubMed Close

nutrition) have been shown to interact (including through metabolic syndrome, MetS) and contribute to CVD. White adipose tissue (WAT) has been identified as a metabolically active endocrine organ that affects a plethora of body functions including energy and

Article Type:
Review Article
DOI:
https://doi.org/10.1530/JOE-12-0232
Volume/Issue:
Volume 216: Issue 1
Free access
Mathis Grossmann Department of Medicine Austin Health, Department of Endocrinology, University of Melbourne, 145 Studley Road, Heidelberg, Victoria 3084, Australia
Department of Medicine Austin Health, Department of Endocrinology, University of Melbourne, 145 Studley Road, Heidelberg, Victoria 3084, Australia

Search for other papers by Mathis Grossmann in
Google Scholar
PubMed Close

for the large proportion of men with metabolic disorders, defined here as type 2 diabetes and or the metabolic syndrome, but without clear-cut classical hypogonadism, is not known. This is because we have insufficient evidence to conclusively answer

Article Type:
Review Article
DOI:
https://doi.org/10.1530/JOE-13-0393
Volume/Issue:
Volume 220: Issue 3
Free access